The Fund's investment objective is to provide long term capital growth by investing in UK smaller companies.
Name | % Net Assets |
---|---|
Anite | 2.9% |
e2v technologies | 2.3% |
Dechra Pharmaceuticals | 2.3% |
TT Electronics | 2.2% |
Cineworld Group | 2.2% |
Vitec Group | 2.2% |
Morgan Sindall Group | 2.0% |
John Menzies | 1.9% |
Workspace Group | 1.9% |
Cental Rand Gold | 1.9% |
Key | % Net Assets |
---|---|
Anite | 2.9% |
e2v technologies | 2.3% |
Dechra Pharmaceuticals | 2.3% |
TT Electronics | 2.2% |
Other | 90.3% |
Date | 11-Aug-2014 |
---|---|
NAV | 93.85p |
Currency | GBP |
Change | -0.30p |
% | -0.19% |
YTD change | 93.85p |
YTD % | n/a |
Fund Inception | 31/08/1996 |
---|---|
Fund Manager | n/a |
TER | 1.46 (15-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research